{"id":10372,"date":"2026-06-30T10:33:30","date_gmt":"2026-06-30T02:33:30","guid":{"rendered":"https:\/\/regask.com\/?p=10372"},"modified":"2026-06-30T10:33:30","modified_gmt":"2026-06-30T02:33:30","slug":"aplicacion-de-las-buenas-practicas-de-fabricacion-bpf-en-junio-de-2026","status":"publish","type":"post","link":"https:\/\/regask.com\/es\/gmp-enforcement-june-2026\/","title":{"rendered":"Intensifican las medidas de control de las Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF): Cartas de advertencia de la FDA, importaciones\u2026"},"content":{"rendered":"<p id=\"ember1956\" class=\"ember-view reader-text-block__paragraph\"><span class=\"TextRun SCXW61959956 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW61959956 BCX0\"><strong>La aplicaci\u00f3n de las Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF) se intensific\u00f3 notablemente a mediados de 2026, y las inspecciones de fabricaci\u00f3n registraron el mayor porcentaje de alertas regulatorias de riesgo entre nuestras principales tendencias en Ciencias de la Vida.<\/strong> El detonante fue un claro aumento en la actuaci\u00f3n de la FDA estadounidense.\u00a0<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">(<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">una serie de cartas de advertencia de CGMP junto con detenciones de importaciones ampliadas<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">)<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">\u00a0junto con la actividad de inspecci\u00f3n en Jap\u00f3n y Latinoam\u00e9rica. Para los equipos de fabricaci\u00f3n y calidad, esta es la tendencia con la consecuencia operativa m\u00e1s directa: la aplicaci\u00f3n de la normativa aqu\u00ed.\u00a0<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">no<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">\u00a0simplemente generar\u00a0<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">papeleo;<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">\u00a0se detiene\u00a0<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">producto<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">\u00a0env\u00edo.<\/span><\/span><span class=\"EOP Selected SCXW61959956 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:0,&quot;335559739&quot;:0}\">\u00a0<\/span><\/p>\n\t<div id=\"gap-257816551\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-257816551 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h3><strong><span class=\"TextRun MacChromeBold SCXW170068198 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW170068198 BCX0\">La FDA elev\u00f3 el nivel de las cartas de advertencia sobre las Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF) y las alertas de importaci\u00f3n.<\/span><\/span><\/strong><\/h3>\n\t<div id=\"gap-1555676772\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1555676772 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"NormalTextRun SCXW80589066 BCX0\">La FDA emiti\u00f3 una serie de cartas de advertencia citando deficiencias significativas en las Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF).\u00a0<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">(<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">en instalaciones de fabricaci\u00f3n est\u00e9ril, producci\u00f3n de ingredientes farmac\u00e9uticos activos (API) y subcontrataci\u00f3n.<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">)\u00a0<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">y la detenci\u00f3n ampliada sin examen f\u00edsico para medicamentos que no cumplen con las Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF) en la frontera. La combinaci\u00f3n es lo que lo hace grave: una carta de advertencia da\u00f1a la reputaci\u00f3n de un sitio, mientras que la detenci\u00f3n de importaciones convierte un hallazgo de incumplimiento en una infracci\u00f3n inmediata.\u00a0<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">suministro de<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">\u00a0interrupci\u00f3n. La garant\u00eda de esterilidad, la integridad de los datos y los controles de API se repitieron a lo largo de las cartas.<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">,\u00a0<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">Precisamente ah\u00ed es donde la remediaci\u00f3n es m\u00e1s lenta. Un sitio web con una alerta de importaci\u00f3n puede ser bloqueado del mercado estadounidense mucho antes de que se resuelvan los problemas subyacentes.<\/span><\/p>\n<h3><strong><span class=\"TextRun MacChromeBold SCXW76108789 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW76108789 BCX0\">La PMDA de Jap\u00f3n public\u00f3 los resultados de la inspecci\u00f3n de Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF).<\/span><\/span><\/strong><\/h3>\n\t<div id=\"gap-440105014\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-440105014 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"NormalTextRun SCXW28283816 BCX0\">La PMDA de Jap\u00f3n public\u00f3 un informe de caso de inspecci\u00f3n de BPM centrado en la gesti\u00f3n de ingredientes farmac\u00e9uticos activos. Los informes de casos son valiosos de una manera que las gu\u00edas gen\u00e9ricas no lo son: muestran las expectativas reales de los inspectores y los modos de falla espec\u00edficos que se\u00f1alan, lo cual es mucho m\u00e1s pr\u00e1ctico que los principios en abstracto. Los equipos de calidad deber\u00edan analizar informes como este para identificar los puntos de control concretos que les importan a los inspectores.\u00a0<\/span><span class=\"NormalTextRun SCXW28283816 BCX0\">(<\/span><span class=\"NormalTextRun SCXW28283816 BCX0\">muestreo, documentaci\u00f3n, cualificaci\u00f3n de proveedores<\/span><span class=\"NormalTextRun SCXW28283816 BCX0\">)<\/span><span class=\"NormalTextRun SCXW28283816 BCX0\">\u00a0y comparar su propia supervisi\u00f3n de la API con los resultados antes de que lo haga un inspector.<\/span><\/p>\n<h3><strong><span class=\"TextRun MacChromeBold SCXW154821105 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW154821105 BCX0\">La Rep\u00fablica Dominicana extendi\u00f3 las inspecciones a los medicamentos importados.<\/span><\/span><\/strong><\/h3>\n\t<div id=\"gap-601556223\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-601556223 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW41450848 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW41450848 BCX0\">El DIGEMAPS de la Rep\u00fablica Dominicana extendi\u00f3 su gu\u00eda de inspecci\u00f3n de Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF) a los medicamentos fabricados en el extranjero e importados. La extensi\u00f3n del alcance a las instalaciones en el extranjero forma parte de una tendencia regional m\u00e1s amplia: los reguladores exigen cada vez m\u00e1s garant\u00edas sobre toda la cadena de fabricaci\u00f3n, no solo sobre las instalaciones nacionales. Para los fabricantes que exportan a estos mercados, el estado de BPF de una instalaci\u00f3n en el extranjero ahora puede\u00a0<\/span><span class=\"NormalTextRun SCXW41450848 BCX0\">determinar<\/span><span class=\"NormalTextRun SCXW41450848 BCX0\"> El acceso a mercados que antes depend\u00edan de la supervisi\u00f3n del pa\u00eds exportador se ve dificultado, y un problema en una planta puede provocar el cierre de varios mercados a la vez.<\/span><\/span><span class=\"EOP SCXW41450848 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:0,&quot;335559739&quot;:0}\">\u00a0<\/span><\/p>\n<h3><strong><span class=\"NormalTextRun SCXW224609958 BCX0\">Qu\u00e9\u00a0<\/span><span class=\"NormalTextRun SCXW224609958 BCX0\">\u00bfEsto hace esto?<\/span><span class=\"NormalTextRun SCXW224609958 BCX0\">\u00a0<\/span><span class=\"NormalTextRun SCXW224609958 BCX0\">significar<\/span><span class=\"NormalTextRun SCXW224609958 BCX0\">\u00a0para\u00a0<\/span><span class=\"NormalTextRun SCXW224609958 BCX0\">\u00bfFabricantes?<\/span><\/strong><\/h3>\n\t<div id=\"gap-2120237973\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-2120237973 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"NormalTextRun SCXW116620405 BCX0\">Con la FDA intensificando la vigilancia dentro y fuera de sus fronteras y las inspecciones en Jap\u00f3n y Am\u00e9rica Latina ampliando su alcance, la aplicaci\u00f3n de las Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF) se est\u00e1 intensificando y <\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">globalizaci\u00f3n<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">. Pruebe a presi\u00f3n los reguladores de control.\u00a0<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">citando<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">\u00a0<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">(<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">garant\u00eda de esterilidad, integridad de los datos y gesti\u00f3n de API<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">)<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">\u00a0y confirmar el cumplimiento de las normas de importaci\u00f3n antes de que se retengan los env\u00edos. En un contexto cada vez m\u00e1s estricto, el costo de una deficiencia en las Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF) se mide en productos detenidos y mercados cerrados, no solo en horas de subsanaci\u00f3n.\u00a0<\/span><a href=\"http:\/\/regask.com\/es\/\"><strong><span class=\"NormalTextRun SpellingErrorV2Themed SCXW116620405 BCX0\">RegASK<\/span><\/strong><\/a><span class=\"NormalTextRun SCXW116620405 BCX0\">\u00a0Realiza un seguimiento de los resultados de las inspecciones de Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF), las cartas de advertencia y las alertas de importaci\u00f3n en todos los organismos reguladores mundiales, lo que ayuda a los equipos de fabricaci\u00f3n y calidad a anticiparse a las medidas de control cada vez m\u00e1s estrictas.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>GMP enforcement escalated noticeably in mid-2026, and manufacturing inspections carried the highest share of risky regulatory alerts among our top Life Sciences trends. The driver was a clear surge in US FDA action\u00a0(a run of CGMP warning letters paired with expanded import detentions)\u00a0alongside inspection activity in Japan and Latin America. For manufacturing and quality teams,&#8230;<\/p>","protected":false},"author":46,"featured_media":10375,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10372","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blogs"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.8 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>GMP Enforcement 2026: Key Regulatory Changes Ahead<\/title>\n<meta name=\"description\" content=\"Explore GMP enforcement 2026 and its impact on manufacturing inspections and regulatory alerts in the Life Sciences sector.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/aplicacion-de-las-buenas-practicas-de-fabricacion-bpf-en-junio-de-2026\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GMP Enforcement Escalates: FDA Warning Letters, Import Alerts &amp; Global Inspections\" \/>\n<meta property=\"og:description\" content=\"Explore GMP enforcement 2026 and its impact on manufacturing inspections and regulatory alerts in the Life Sciences sector.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/aplicacion-de-las-buenas-practicas-de-fabricacion-bpf-en-junio-de-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-30T02:33:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2026\/06\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Shaffa Renaningtyas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shaffa Renaningtyas\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/\"},\"author\":{\"name\":\"Shaffa Renaningtyas\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/6d86c29c9123b2b67a3ea8e259cdb925\"},\"headline\":\"GMP Enforcement Escalates: FDA Warning Letters, Import &hellip;\",\"datePublished\":\"2026-06-30T02:33:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/\"},\"wordCount\":504,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png\",\"articleSection\":[\"Blogs\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/\",\"name\":\"GMP Enforcement 2026: Key Regulatory Changes Ahead\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png\",\"datePublished\":\"2026-06-30T02:33:30+00:00\",\"description\":\"Explore GMP enforcement 2026 and its impact on manufacturing inspections and regulatory alerts in the Life Sciences sector.\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png\",\"width\":800,\"height\":600,\"caption\":\"Gmp Enforcement Escalates Fda Warning Letters Import Alerts & Global Inspections\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/6d86c29c9123b2b67a3ea8e259cdb925\",\"name\":\"Shaffa Renaningtyas\",\"sameAs\":[\"https:\\\/\\\/regask.com\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Aplicaci\u00f3n de las Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF) en 2026: Cambios regulatorios clave en el futuro","description":"Analizamos la aplicaci\u00f3n de las Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF) en 2026 y su impacto en las inspecciones de fabricaci\u00f3n y las alertas regulatorias en el sector de las ciencias biol\u00f3gicas.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/aplicacion-de-las-buenas-practicas-de-fabricacion-bpf-en-junio-de-2026\/","og_locale":"es_ES","og_type":"article","og_title":"GMP Enforcement Escalates: FDA Warning Letters, Import Alerts & Global Inspections","og_description":"Explore GMP enforcement 2026 and its impact on manufacturing inspections and regulatory alerts in the Life Sciences sector.","og_url":"https:\/\/regask.com\/es\/aplicacion-de-las-buenas-practicas-de-fabricacion-bpf-en-junio-de-2026\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2026-06-30T02:33:30+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/06\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png","type":"image\/png"}],"author":"Shaffa Renaningtyas","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Shaffa Renaningtyas","Est. reading time":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/#article","isPartOf":{"@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/"},"author":{"name":"Shaffa Renaningtyas","@id":"https:\/\/regask.com\/#\/schema\/person\/6d86c29c9123b2b67a3ea8e259cdb925"},"headline":"GMP Enforcement Escalates: FDA Warning Letters, Import &hellip;","datePublished":"2026-06-30T02:33:30+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/"},"wordCount":504,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/06\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png","articleSection":["Blogs"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/","url":"https:\/\/regask.com\/gmp-enforcement-june-2026\/","name":"Aplicaci\u00f3n de las Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF) en 2026: Cambios regulatorios clave en el futuro","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/06\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png","datePublished":"2026-06-30T02:33:30+00:00","description":"Analizamos la aplicaci\u00f3n de las Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF) en 2026 y su impacto en las inspecciones de fabricaci\u00f3n y las alertas regulatorias en el sector de las ciencias biol\u00f3gicas.","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/gmp-enforcement-june-2026\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/06\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/06\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png","width":800,"height":600,"caption":"Gmp Enforcement Escalates Fda Warning Letters Import Alerts & Global Inspections"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"El sistema operativo de IA regulatoria para equipos de alto rendimiento","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/6d86c29c9123b2b67a3ea8e259cdb925","name":"Shaffa Renaningtyas","sameAs":["https:\/\/regask.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/10372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/46"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=10372"}],"version-history":[{"count":3,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/10372\/revisions"}],"predecessor-version":[{"id":10376,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/10372\/revisions\/10376"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/10375"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=10372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/categories?post=10372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/tags?post=10372"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}